The global market for disposable medical gloves is projected to reach $4 billion by the year 2017, driven primarily by rising emphasis on health, occupational safety and hygiene among end-users in the healthcare market.
Â
According to a new report, despite the challenging economic conditions worldwide, the disposable medical gloves market continues to post positive growth primarily attributed to the inherent intrinsic indispensability of the product among surgeons, practitioners and healthcare workers. Currently, there exists immense opportunities for growth in the disposable medical gloves market given the fact that dozens of pairs of medical gloves are used in a single day in hospitals and laboratory settings, Further, a vast portion of the global market still remains untapped with Asia and Latin America holding the highest potential for disposable medical gloves. Over the years, regulatory frameworks and concerns such as worker safety and welfare have contributed to market growth across the globe. Increase in global population and rise in personal and occupational hygiene standards amid outbreak of various infections such as avian flu, SARS and HIV continue to sustain market growth.
Â
As stated by the new market research report, the U.S. continues to remain the largest regional market. Asia-Pacific constitutes the fastest growing market for medical gloves. The Asian medical glove industry is beginning to witness major changes in end-user preferences, brand positioning, and competition. With growing demand for powder-free and synthetic gloves in domestic and foreign markets, Asian manufacturers are beginning to diversify their product portfolio to incorporate powder free medical gloves. Rising awareness regarding latex caused allergens, and increased innovation, and technology breakthroughs in synthetic variants together are expected to sustain growth of the surgical gloves market.
Â
Major players in the marketplace include Ansell Healthcare, B. Braun Melsungen AG, Cardinal Health, Inc., Cypress Medical Products, Dynarex Corporation, Kimberly-Clark Worldwide, Medline Industries, Molnlycke Health Care, Microflex Medical Corp., Paul Hartmann AG, Siam Sempermed Corporation Ltd., Semperit AG Holding, Supermax Corporation Berhad, among others.
Â
The research report titled "Disposable Medical Gloves: A Global Strategic Business Report" announced by Global Industry Analysts, Inc., provides a comprehensive review of trends, issues, strategic industry activities, and profiles of major companies worldwide. The report provides annual sales estimates and projections for Disposable Medical Gloves market for the years 2009 through 2017, and 2003 to 2008 by the following geographic markets - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Key segments and sub-segments analyzed include Examination Gloves (Powdered and Powder Free) and Surgical Gloves (Powdered and Powder Free).
Â
COVID-19 Harmonization: Balancing Risks and Benefits of CDC's Latest Move
March 11th 2024The CDC's recent decision to align recommendations for respiratory viruses, particularly COVID-19, has garnered support from the public and infectious disease societies. However, as the Infectious Diseases Society of America (IDSA) lends its backing to the CDC's harmonization efforts, concerns persist regarding the implications of this shift, especially considering the Omicron variant's unique characteristics and the ongoing challenges posed by COVID-19's multi-system impacts.
Voices of Resilience: Q&A With the Editor of "Corona City: Voices From an Epicenter"
March 1st 2024Step into the diverse and poignant world of "Corona City: Voices From an Epicenter" with editor Lorraine Ash, MA. In this insightful Q&A, learn about the origins of this remarkable anthology, the challenges faced in capturing raw, unfiltered narratives of the COVID-19 pandemic, and the lasting impact of these stories on readers and communities alike.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.
COVID-19 Realities: Beyond a Respiratory Virus, Addressing Optimism in Pandemic Management
February 28th 2024A recent commentary by Dr. Amesh Adalja in MedPage Today challenges the perception of COVID-19 as solely a respiratory virus, highlighting its broader impact on the body. This analysis questions the notion that COVID-19 should be managed like common respiratory infections, urging a closer look at vaccine effectiveness, the rise of long COVID, and the need for enhanced measures to curb the virus's spread. Let's explore the complexities of COVID-19 management and the pressing realities faced by the US and the world.